Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer

BOSTON, Sept. 27, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug candidates. In the collaboration, Pfizer will leverage to advance the discovery and development of novel RNA molecules across…#boston #ginkgobioworks #pfe #rna #pfizer #ginkgo #willsomers #jasonkelly #rnacodebase #foundry

Source: Reuters: Health - September 27, 2023 Category: Consumer Health News Source Type: news